SciELO - Scientific Electronic Library Online

 
vol.14 número5Estado actual de las unidades de dolor agudo en AndalucíaParche de lidocaína al 5% para el tratamiento del SDRC de extremidad superior por bloqueo transcutáneo del plexo braquial: Caso Clínico índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Sociedad Española del Dolor

versão impressa ISSN 1134-8046

Resumo

CALDERON, E. et al. Oxycodone in non-oncological chronic pain: Effects on quality of life parameters. Rev. Soc. Esp. Dolor [online]. 2007, vol.14, n.5, pp.346-350. ISSN 1134-8046.

Objectives: To evaluate the effectiveness and safety of controlled reléase oxicodone in mixed pain mixed in patients with non oncológical severe pain, as well as its interference on the pain and quality of life. Material and Methods: Prospective study. 34 patients with mixed pain (nociceptive and neuropáthic). 1 month minimum pain duration. The brief questionnaire for the evaluation of the pain was used (CBD), the interference with functional parameters of quality of life: general activity, mood, walking, work, relationship with other people and sleep. Starting oxicodone controlled reléaselo mg/12 h and rescue analgesia with oxicodone fast reléase 20 mg/day with progressive increase every 15 days until obtaining adapted control of the pain. Acetaminophen 650 mg/6 h was used as associate medication. The patients were evaluated at 30 and 60 days. Results: The average age of our patients was of 69 ± 7 years, the average dose of oxicodone to provide a suitable control of the pain were 37 ± 6 mg to the day. Oxicodone significantly reduce the intensity of severe pain after 30 and 60 days of treatment, and respectively provided a lightening of the pain 48% and 67%. The parameters of sleeping and relationship with the others improved significantly at the end of the study. The most frequent adverse event was constipation (14,7%). Conclusions: Controlled reléase oxicodone 37 mg/day provides a significant reduction in the intensity of severe pain lasting until second month of treatment with an improvement in the of quality of life.

Palavras-chave : Opiate; oxicodone; nononcológical chronic pain; brief questionnaire pain; quality of life.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons